Litcius/Paper detail

[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease].

Zhen-xin Zhao, Hao Bai, jinhui duan, J. Wang

2020PubMed13 citationsDOI

Abstract

In order to achieve the overall victory over 2019 novel coronavirus disease epidemic, especially to prevent the disease recurrence from rebounding during the resumption of labor, the government has not loosened any control of personnel mobility, which has obviously affected the normal examination and treatment of lung cancer patients under the influence of this epidemic. During the epidemic period, cancer patients with low immunity levels face the double ordeals of disease and epidemic situation. Compared with the general population, they are more likely to be infected with the new coronavirus. Among the infected cancer patients, lung cancer is the most common type. It is necessary to provide more appropriate individualized treatment recommendations for patients with lung cancer based on the epidemic situation of the patient's location and in combination with the patient's own condition. Through active prevention of infection, timely conversion of treatment strategies, online and offline joint control, and positive psychological counseling, we do our best to help patients with lung cancer to survive this difficult period.

Topics & Concepts

MedicineDiseaseLung cancerCancerPopulationOutbreakIntensive care medicineCoronavirusInternal medicineTreatment of lung cancerSurgeryOncologyCoronavirus disease 2019 (COVID-19)PathologyEnvironmental healthInfectious disease (medical specialty)COVID-19 and healthcare impactsEconomic and Financial Impacts of CancerMultiple and Secondary Primary Cancers
[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease]. | Litcius